PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Hydatidiform mole is a rare mass or growth that forms inside the womb (uterus) at the beginning of a pregnancy. It is a type gestational trophoblastic disease (GTD). A cancerous form of GTD is called choriocarcinoma.
Causes, incidence, and risk factors
Hydatidiform mole, or molar pregnancy, results from over-production of the tissue that is supposed to develop into the placenta. The placenta feeds the fetus during pregnancy. With a molar pregnancy, the tissues develop into an abnormal growth, called a mass.
There are two types:
- Partial molar pregnancy: There is an abnormal placenta and some fetal development.
- Complete molar pregnancy: There is an abnormal placenta but no fetus.
Both forms are due to problems during fertilization. The exact cause of fertilization problems is unknown. A diet low in protein, animal fat, and vitamin A may play a role.
Symptoms
- Abnormal growth of the womb (uterus)
- Excessive growth in about half of cases
- Smaller-than-expected growth in about a third of cases
- Nausea and vomiting that may be severe enough to require a hospital stay
- Vaginal bleeding in pregnancy during the first 3 months of pregnancy
- Symptoms of hyperthyroidism
- Restlessness, nervousness
- Skin warmer and more moist than usual
- Symptoms similar to preeclampsia that occur in the 1st trimester or early 2nd trimester -- this is almost always a sign of a hydatidiform mole, because preeclampsia is extremely rare this early in a normal pregnancy
- High blood pressure
- Swelling in feet, ankles, legs
Signs and tests
A pelvic examination may show signs similar to a normal pregnancy, but the size of the womb may be abnormal and the baby's heart sounds are absent. There may be some vaginal bleeding.
A pregnancy ultrasound will show an abnormal placenta with or without some development of a baby.
Tests may include:
- Chest x-ray
- CT or MRI of the abdomen
- Complete blood count
- Blood clotting tests
- Kidney and liver function tests
Treatment
If your doctor suspects a molar pregnancy, a suction curettage (D and C) may be performed.
A hysterectomy may be an option for older women who do not wish to become pregnant in the future.
After treatment, serum HCG level will be followed. It is important to avoid pregnancy and to use a reliable contraceptive for 6 - 12 months after treatment for a molar pregnancy. This allows for accurate testing to be sure that the abnormal tissue does not grow back. Women who get pregnant too soon after a molar pregnancy have a high risk of having another molar pregnancy.
Expectations (prognosis)
More than 80% of hydatidiform moles are benign (noncancerous). Treatment is usually successful. Close follow-up by your doctor is important. After treatment, use effective contraception for at least 6 - 12 months to avoid pregnancy.
In some cases, hydatidiform moles develop into invasive moles. These can grow deep into the uterine wall and cause bleeding or other complications.
In a few cases, a hydatidiform mole develops into a choriocarcinoma. This is a fast-growing cancerous form of gestational trophoblastic disease.
Complications
Lung problems may occur after a D and C if the mother's uterus is larger than 16 weeks gestational size.
Complications of molar pregnancy include:
- Thyroid problems
- Molar pregnancy that continues or comes back
Complications related to the surgery to remove a molar pregnancy include:
- Excessive bleeding
- Side effects of anesthesia
References
- Copeland LJ, Landon MB. Malignant diseases and pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics - Normal and Problem Pregnancies. 6th ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 47.
- Goldstein DP, Berkowitz RS. Gestational trophoblastic disease. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2008:chap 94.
- Kavanagh JJ, Gershenson DM. Gestational trophoblastic disease: hydatidiform mole, nonmetastatic and metastatic gestational trophoblastic tumor: diagnosis and management. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 6th ed. Philadelphia, PA: Elsevier Mosby; 2012:chap 35.
Review Date: 11/8/2012.
Reviewed by: Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Bellevue, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, David R. Eltz, Stephanie Slon, and Nissi Wang.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Anti‐cancer drug treatment for gestational trophoblastic neoplasia (GTN) that does not respond to first‐line treatment or that re‐occurs
This review concerns anti‐cancer drug treatment for women with GTN that does not respond to first‐line treatment or that re‐occurs. GTN is the name given to a type of cancer that arises from placental tissue following pregnancy, most frequently a molar pregnancy. Molar pregnancies are benign abnormal growths of placental tissue inside the womb. Most are cured by evacuation (D&C) of the womb, however, in up to 20% of cases they become malignant. GTN is usually very responsive to anti‐cancer drugs (chemotherapy), however, these drugs can be toxic, therefore the aim of treatment is to achieve a cure with the least side effects. To help doctors select the most appropriate treatment for women with GTN, the disease is classified as low‐ or high‐risk according to specific risk factors.
No proof found that depression is 'contagious'22 April 2013'Can you catch depression?', the Mail Online website asks on the strength of new US research into the concept of 'cognitive vulnerability'. Cognitive vulnerability is where unhelpful patterns of thin...
- Hydatidiform moleHydatidiform molePubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...
